rs115680381
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001286445.3(RIPOR2):c.3044-12T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00753 in 1,522,738 control chromosomes in the GnomAD database, including 56 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0060 ( 7 hom., cov: 33)
Exomes 𝑓: 0.0077 ( 49 hom. )
Consequence
RIPOR2
NM_001286445.3 intron
NM_001286445.3 intron
Scores
2
Splicing: ADA: 0.00008783
2
Clinical Significance
Conservation
PhyloP100: 1.94
Genes affected
RIPOR2 (HGNC:13872): (RHO family interacting cell polarization regulator 2) This gene encodes an atypical inhibitor of the small G protein RhoA. Inhibition of RhoA activity by the encoded protein mediates myoblast fusion and polarization of T cells and neutrophils. The encoded protein is a component of hair cell stereocilia that is essential for hearing. A splice site mutation in this gene results in hearing loss in human patients. [provided by RefSeq, Sep 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 6-24806485-A-G is Benign according to our data. Variant chr6-24806485-A-G is described in ClinVar as [Benign]. Clinvar id is 517552.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 7 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RIPOR2 | NM_001286445.3 | c.3044-12T>C | intron_variant | ENST00000643898.2 | NP_001273374.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RIPOR2 | ENST00000643898.2 | c.3044-12T>C | intron_variant | NM_001286445.3 | ENSP00000494268.2 | |||||
ENSG00000282804 | ENST00000562221.1 | c.83-12T>C | intron_variant | 5 | ENSP00000455145.1 |
Frequencies
GnomAD3 genomes AF: 0.00599 AC: 895AN: 149392Hom.: 7 Cov.: 33
GnomAD3 genomes
AF:
AC:
895
AN:
149392
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00559 AC: 772AN: 138184Hom.: 4 AF XY: 0.00568 AC XY: 416AN XY: 73192
GnomAD3 exomes
AF:
AC:
772
AN:
138184
Hom.:
AF XY:
AC XY:
416
AN XY:
73192
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00770 AC: 10571AN: 1373228Hom.: 49 Cov.: 25 AF XY: 0.00738 AC XY: 5009AN XY: 678280
GnomAD4 exome
AF:
AC:
10571
AN:
1373228
Hom.:
Cov.:
25
AF XY:
AC XY:
5009
AN XY:
678280
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00598 AC: 894AN: 149510Hom.: 7 Cov.: 33 AF XY: 0.00558 AC XY: 407AN XY: 72884
GnomAD4 genome
AF:
AC:
894
AN:
149510
Hom.:
Cov.:
33
AF XY:
AC XY:
407
AN XY:
72884
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 24, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 23, 2017 | c.3107-12T>C in intron 22 of FAM65B: This variant is not expected to have clinic al significance because it does not alter an amino acid residue, is not located within the splice consensus sequence, and has been identified in 0.82% (76/9312) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac. broadinstitute.org; dbSNP rs115680381). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at